|
MechanismCXCR4 antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date15 Dec 2008 |
100 Clinical Results associated with SEACROSS PHARMACEUTICALS LTD
0 Patents (Medical) associated with SEACROSS PHARMACEUTICALS LTD
100 Deals associated with SEACROSS PHARMACEUTICALS LTD
100 Translational Medicine associated with SEACROSS PHARMACEUTICALS LTD